Menu

IDEAYA Biosciences, Inc. IDYA

Full chart Compare
Set alert

Price alert · IDYA

All alert types
31.24 USD +0.59 (+1.92%)

At closeNov 6, 2026, 4:00 PM EST

31.24 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

30.45 Day range 31.33
27.60 52-week range 42.48
YTD
-9.63%
1 year
+4.66%

Revenue & Expenses

Other Income → Expenses: $45.62MExpenses → Gross Loss: $95.99MExpenses → Selling, General & Admin: $63.32MExpenses → Research & Development: $314.70MOther Operating Income → Expenses: $314.70MNet Loss → Expenses: $113.70MRevenue → Cost of Revenue: $218.71MOther Income$45.62MOther Operating Income$314.70MNet Loss$113.70MCost of Revenue$314.70MExpenses$474.02MGross Loss$95.99MSelling, General & Admin$63.32MResearch & Development$314.70MRevenue$218.71M

Latest period ending Dec 31, 2025 · select a line to chart its full history

IDYA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
218.71M7.00M23.39M50.93M27.94M
218.71M7.00M23.39M50.93M27.94M
-159.31M-326.98M-134.43M-62.50M-50.27M
-113.70M-274.48M-112.96M-58.66M-49.76M
-1.28-3.36-1.96-1.42-1.41
IDYA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
113.84M85.18M157.78M68.74M92.15M
1.11B1.12B649.32M387.97M381.35M
86.39M64.94M28.23M38.51M79.83M
27.91M19.17M2.87M3.48M5.18M
1.02B1.06B621.09M349.45M301.51M
IDYA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-71.10M-247.58M-115.22M-87.17M-55.78M
69.98M-502.56M-158.46M-33.40M-69.67M
29.78M677.55M362.72M97.17M145.45M
-2.37M-3.86M-2.37M-3.44M-2.64M
28.66M-72.59M89.04M-23.41M20.01M